209
Views
3
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Plasma 25(OH)D Level is Associated with the Nucleic Acid Negative Conversion Time of COVID-19 Patients: An Exploratory Study

, ORCID Icon, , , , , , & show all
Pages 937-947 | Received 07 Dec 2022, Accepted 09 Feb 2023, Published online: 15 Feb 2023

References

  • Ye Q, Wang B, Mao J, et al. Epidemiological analysis of COVID-19 and practical experience from China. J Med Virol. 2020;92(7):755–769. doi:10.1002/jmv.25813
  • Zhang X, Zhang W, Chen S. Shanghai’s life-saving efforts against the current omicron wave of the COVID-19 pandemic [published correction appears in Lancet. 2022 May 19;:]. Lancet. 2022;399(10340):2011–2012. doi:10.1016/S0140-6736(22)00838-8
  • Cheung PH, Chan CP, Jin DY. Lessons learned from the fifth wave of COVID-19 in Hong Kong in early 2022. Emerg Microbes Infect. 2022;11(1):1072–1078. doi:10.1080/22221751.2022.2060137
  • Diagnosis and treatment protocol for novel coronavirus pneumonia (Trial Version 9); 2022. Available from: http://www.gov.cn/zhengce/zhengceku/2022-03/15/content_5679257.htm. Accessed February 11, 2023.
  • Luo L, Ye J, Shao C, et al. Vitamin D status presents different relationships with severity in metabolic-associated fatty liver disease patients with or without hepatitis B infection. Nutrients. 2022;14(10):2114. doi:10.3390/nu14102114
  • Jeon SM, Shin EA. Exploring vitamin D metabolism and function in cancer. Exp Mol Med. 2018;50(4):1–14. doi:10.1038/s12276-018-0038-9
  • de La Puente-Yagüe M, Cuadrado-Cenzual MA, Ciudad-Cabañas MJ, Hernández-Cabria M, Collado-Yurrita L. Vitamin D: and its role in breast cancer. Kaohsiung J Med Sci. 2018;34(8):423–427. doi:10.1016/j.kjms.2018.03.004
  • Jagannath VA, Filippini G, Di Pietrantonj C, et al. Vitamin D for the management of multiple sclerosis. Cochrane Database Syst Rev. 2018;9(9):CD008422. doi:10.1002/14651858.CD008422.pub3
  • Martineau AR, Jolliffe DA, Hooper RL, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017;356:i6583. doi:10.1136/bmj.i6583
  • Kaufman HW, Niles JK, Kroll MH, Bi C, Holick MF. SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels. PLoS One. 2020;15(9):e0239252. doi:10.1371/journal.pone.0239252
  • Merzon E, Tworowski D, Gorohovski A, et al. Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study. FEBS J. 2020;287(17):3693–3702. doi:10.1111/febs.15495
  • D’Avolio A, Avataneo V, Manca A, et al. 25-hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2. Nutrients. 2020;12(5):1359. doi:10.3390/nu12051359
  • Im JH, Je YS, Baek J, Chung MH, Kwon HY, Lee JS. Nutritional status of patients with COVID-19. Int J Infect Dis. 2020;100:390–393. doi:10.1016/j.ijid.2020.08.018
  • Abdollahi A, Kamali Sarvestani H, Rafat Z, et al. The association between the level of serum 25(OH) vitamin D, obesity, and underlying diseases with the risk of developing COVID-19 infection: a case-control study of hospitalized patients in Tehran, Iran. J Med Virol. 2021;93(4):2359–2364. doi:10.1002/jmv.26726
  • Liu N, Sun J, Wang X, Zhang T, Zhao M, Li H. Low vitamin D status is associated with coronavirus disease 2019 outcomes: a systematic review and meta-analysis. Int J Infect Dis. 2021;104:58–64. doi:10.1016/j.ijid.2020.12.077
  • De Smet D, De Smet K, Herroelen P, Gryspeerdt S, Martens GA. Serum 25(OH)D level on hospital admission associated with COVID-19 stage and mortality. Am J Clin Pathol. 2021;155(3):381–388. doi:10.1093/ajcp/aqaa252
  • Baktash V, Hosack T, Patel N, et al. Vitamin D status and outcomes for hospitalised older patients with COVID-19. Postgrad Med J. 2021;97(1149):442–447. doi:10.1136/postgradmedj-2020-138712
  • Entrenas Castillo M, Entrenas Costa LM, Vaquero Barrios JM, et al. Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: a pilot randomized clinical study. J Steroid Biochem Mol Biol. 2020;203:105751. doi:10.1016/j.jsbmb.2020.105751
  • Murai IH, Fernandes AL, Sales LP, et al. Effect of a single high dose of vitamin D3 on hospital length of stay in patients with moderate to severe COVID-19: a randomized clinical trial. JAMA. 2021;325(11):1053–1060. doi:10.1001/jama.2020.26848
  • Arora J, Patel DR, Nicol MJ, et al. Vitamin D and the ability to produce 1,25(OH)2D are critical for protection from viral infection of the lungs. Nutrients. 2022;14(15):3061. doi:10.3390/nu14153061
  • Jolliffe DA, Griffiths CJ, Martineau AR. Vitamin D in the prevention of acute respiratory infection: systematic review of clinical studies. J Steroid Biochem Mol Biol. 2013;136:321–329. doi:10.1016/j.jsbmb.2012.11.017
  • Zhu Z, Zhu X, Gu L, Zhan Y, Chen L, Li X. Association between vitamin D and influenza: meta-analysis and systematic review of randomized controlled trials. Front Nutr. 2022;8:799709. doi:10.3389/fnut.2021.799709
  • Lau FH, Majumder R, Torabi R, et al. Vitamin D insufficiency is prevalent in severe COVID-19. medRxiv. 2020. doi:10.1101/2020.04.24.20075838
  • Daneshkhah A, Agrawal V, Eshein A, Subramanian H, Roy HK, Backman V. Evidence for possible association of vitamin D status with cytokine storm and unregulated inflammation in COVID-19 patients. Aging Clin Exp Res. 2020;32(10):2141–2158. doi:10.1007/s40520-020-01677-y
  • Rhodes J, Dunstan F, Laird E, Subramanian S, Kenny RA. COVID-19 mortality increases with northerly latitude after adjustment for age suggesting a link with ultraviolet and vitamin D. BMJ Nutr Prev Health. 2020;3(1):118–120. doi:10.1136/bmjnph-2020-000110
  • Charan J, Goyal JP, Saxena D, Yadav P. Vitamin D for prevention of respiratory tract infections: a systematic review and meta-analysis. J Pharmacol Pharmacother. 2012;3(4):300–303. doi:10.4103/0976-500X.103685
  • Bergman P, Lindh AU, Björkhem-Bergman L, Lindh JD. Vitamin D and respiratory tract infections: a systematic review and meta-analysis of randomized controlled trials. PLoS One. 2013;8(6):e65835. doi:10.1371/journal.pone.0065835
  • Ma H, Zhou T, Heianza Y, Qi L. Habitual use of vitamin D supplements and risk of coronavirus disease 2019 (COVID-19) infection: a prospective study in UK Biobank. Am J Clin Nutr. 2021;113(5):1275–1281. doi:10.1093/ajcn/nqaa381
  • Hayashi H, Okamatsu M, Ogasawara H, et al. Oral supplementation of the vitamin D metabolite 25(OH)D3 against influenza virus infection in mice. Nutrients. 2020;12(7):2000. doi:10.3390/nu12072000
  • Xu J, Yang J, Chen J, Luo Q, Zhang Q, Zhang H. Vitamin D alleviates lipopolysaccharide‑induced acute lung injury via regulation of the renin‑angiotensin system. Mol Med Rep. 2017;16(5):7432–7438. doi:10.3892/mmr.2017.7546
  • Tentolouris N, Samakidou G, Eleftheriadou I, Tentolouris A, Jude EB. The effect of vitamin D supplementation on mortality and intensive care unit admission of COVID-19 patients. A systematic review, meta-analysis and meta-regression. Diabetes Metab Res Rev. 2022;38(4):e3517. doi:10.1002/dmrr.3517
  • Fu Y, Han P, Zhu R, et al. Risk factors for viral RNA shedding in COVID-19 patients. Eur Respir J. 2020;56(1):2001190. doi:10.1183/13993003.01190-2020
  • Huang W, Sun Y, Xing Y, Wang C. Functional impairment and serum albumin predict in-hospital mortality in nonagenarians with acute infection: a retrospective cohort study. BMC Geriatr. 2019;19(1):269. doi:10.1186/s12877-019-1301-1
  • Henry BM, Benoit JL, Benoit S, et al. Red Blood Cell Distribution Width (RDW) predicts COVID-19 severity: a prospective, observational study from the Cincinnati SARS-CoV-2 emergency department cohort. Diagnostics. 2020;10(9):618. doi:10.3390/diagnostics10090618
  • Foy BH, Carlson JCT, Reinertsen E, et al. Association of red blood cell distribution width with mortality risk in hospitalized adults with SARS-CoV-2 infection. JAMA Netw Open. 2020;3(9):e2022058. doi:10.1001/jamanetworkopen.2020.22058
  • Wang C, Deng R, Gou L, et al. Preliminary study to identify severe from moderate cases of COVID-19 using combined hematology parameters. Ann Transl Med. 2020;8(9):593. doi:10.21037/atm-20-3391
  • Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [published correction appears in Lancet. 2020 Jan 30;:]. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
  • Di Filippo L, Allora A, Doga M, et al. Vitamin D levels are associated with blood glucose and BMI in COVID-19 patients, predicting disease severity. J Clin Endocrinol Metab. 2022;107(1):e348–e360. doi:10.1210/clinem/dgab599
  • Biesalski HK. Obesity, vitamin D deficiency and old age a serious combination with respect to coronavirus disease-2019 severity and outcome. Curr Opin Clin Nutr Metab Care. 2021;24(1):18–24. doi:10.1097/MCO.0000000000000700
  • Li C, Chen P, Duan X, et al. Bioavailable 25(OH)D but not total 25(OH)D is an independent determinant for bone mineral density in Chinese postmenopausal women. EBioMedicine. 2017;15:184–192. doi:10.1016/j.ebiom.2016.11.029